Paperpal Prime Logo

Marine Drugs : Impact Factor & More

eISSN: 1660-3397pISSN: 1660-3397
JournalOpen Access

Aims and Scope of Marine Drugs

Marine Drugs is a peer-reviewed open-access medical journal publishing reviews and regular research papers on the research, development, and production of therapeutic agents from marine natural products. It is published by MDPI and was established in 2003. The editor-in-chief is Prof. Orazio Taglialatela-Scafati (Università degli Studi di Napoli Federico II, Italy). Less

Key Metrics

CiteScore
8.1
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
Scite Index
0.91 5-Year SI
SJR
Q1Drug Discovery
SNIP
1.31
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Marine Drugs

Marine Drugs Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher MDPI
Language English
Frequency Monthly
Article Processing ChargesCHF 2500
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2003
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Marine Drugs ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Marine Drugs

Apiosporapyrones A–E: α-Pyrone Derivatives from the Sponge-Associated Fungus Apiospora arundinis P-1 with Growth-Inhibitory Effects on MCF-7 Cells
  • 22 Oct 2026
  • Marine Drugs
Antibacterial Dolastane Diterpenes from the Brown Alga Canistrocarpus cervicornis
  • 22 Oct 2026
  • Marine Drugs
Fucoidan–Alginate Composite Nanogels and Hydrogels: Design Strategies, Gelation Mechanisms and Sustainable Applications
  • 22 Oct 2026
  • Marine Drugs
Discovery of a Novel Antiepileptic Bicyclic Norditerpenoid from the Marine Algae-Derived Fungus Chloridium sp. NBU3282
  • 21 Oct 2026
  • Marine Drugs
Microalgae and Cyanobacteria Species Valorization Towards Sustainable Bioplastics Production
  • 20 Oct 2026
  • Marine Drugs
Chemical Constituents of Halophyte Suaeda glauca and Their Anti-Adipogenic and Anti-Inflammatory Activities
  • 20 Oct 2026
  • Marine Drugs
Apiosporapyrones A–E: α-Pyrone Derivatives from the Sponge-Associated Fungus Apiospora arundinis P-1 with Growth-Inhibitory Effects on MCF-7 Cells
  • 22 Oct 2026
  • Marine Drugs
Antibacterial Dolastane Diterpenes from the Brown Alga Canistrocarpus cervicornis
  • 22 Oct 2026
  • Marine Drugs
Fucoidan–Alginate Composite Nanogels and Hydrogels: Design Strategies, Gelation Mechanisms and Sustainable Applications
  • 22 Oct 2026
  • Marine Drugs
Discovery of a Novel Antiepileptic Bicyclic Norditerpenoid from the Marine Algae-Derived Fungus Chloridium sp. NBU3282
  • 21 Oct 2026
  • Marine Drugs
Microalgae and Cyanobacteria Species Valorization Towards Sustainable Bioplastics Production
  • 20 Oct 2026
  • Marine Drugs
Chemical Constituents of Halophyte Suaeda glauca and Their Anti-Adipogenic and Anti-Inflammatory Activities
  • 20 Oct 2026
  • Marine Drugs

FAQs on Marine Drugs